Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ZD4054: Phase II data

In the Phase II EPOC trial in 312 patients, ZD4054 failed

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE